Designed for Gentle. Built for Effective – Micro-Invasive BPH Treatment
EchoLaser TPLA™ brings a new era of micro-invasive BPH treatment – combining ultra-fine needle access, real-time ultrasound navigation and selective laser ablation to treat enlarged tissue with remarkable conservation of structure and function. Patients experience minimal trauma, same-day discharge and improved urinary and sexual health.
Designed for clinicians who value clarity and control, EchoLaser TPLA™ delivers focused thermal ablation exactly where it’s needed, without general anaesthesia or significant side effects. A smarter pathway to safer, patient-first BPH care.
Echo combines ultrasound guidance, ultra-fine transperineal 21G needles and controlled laser energy to ablate hypertrophic prostate tissue while avoiding the urethra and preserving key structures. Flexible laser fibres deliver targeted thermal energy, creating predictable ablation zones with real-time imaging to protect surrounding anatomy.
Supported by the EchoLaser Smart Interface (ESI), clinicians benefit from continuous visual feedback for accurate fibre placement and consistent results. Performed under local anaesthesia, this micro-invasive procedure reduces prostate volume and urinary symptoms while maintaining continence and sexual function, often with same-day discharge.
EchoLaser TPLA™ (Transperineal Laser Ablation) is a micro-invasive, ultrasound-guided laser platform for treating Benign Prostatic Hyperplasia. It reduces prostate volume by delivering controlled thermal energy through fine needles, without entering the urethra.
Under real-time ultrasound guidance, thin 21-gauge needles are inserted transperineally. Laser fibres are then positioned to deliver thermal ablation zones that shrink enlarged prostate tissue while preserving surrounding structures.
TPLA is suitable for patients with BPH symptoms affecting quality of life, including those who are poor candidates for general anaesthesia or traditional surgery due to comorbidities or anticoagulation.
Yes – studies report high preservation rates for ejaculation, continence and erectile function thanks to the tissue-sparing, non-urethral approach.
Most patients return home the same day with minimal discomfort. Recovery is typically rapid, with a lower complication rate compared to traditional surgical options.
Real-time ultrasound guidance and the EchoLaser Smart Interface allow precise visualisation of needle positioning and thermal zones, supporting predictable and reproducible outcomes.
Yes – its outpatient suitability, minimal anesthesia requirements and rapid recovery make it an efficient clinical option for both public and private pathways.
